HAO
Haoxi Health·NASDAQ
--
--(--)
--
--(--)
HAO fundamentals
During FY 2025, Haoxi Health (HAO) reported revenue of 32.80M, a YoY change of -32.39%. Net income was 3.88M, a YoY change of 200.13%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2021 | H1,2022 | FY,2022 | H1,2023 | FY,2023 | H1,2024 | FY,2024 | H1,2025 | FY,2025 | TTM |
|---|
Start Date | Jul 1, 2020 | Jul 1, 2021 | Jul 1, 2021 | Jul 1, 2022 | Jul 1, 2022 | Jul 1, 2023 | Jul 1, 2023 | Jul 1, 2024 | Jul 1, 2024 | -- |
End Date | Jun 30, 2021 | Dec 31, 2021 | Jun 30, 2022 | Dec 31, 2022 | Jun 30, 2023 | Dec 31, 2023 | Jun 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | -- |
Revenue | 12.85M -- | 7.40M -- | 16.16M +25.76% | 9.16M +23.80% | 28.23M +74.72% | 23.50M +156.51% | 48.52M +71.88% | 23.95M +1.92% | 32.80M -32.39% | 32.80M -- |
Sales and Services Revenue | 12.85M -- | 7.40M -- | 16.16M +25.76% | 9.16M +23.80% | 28.23M +74.72% | 23.50M +156.51% | 48.52M +71.88% | 23.95M +1.92% | 32.80M -32.39% | 32.80M -- |
Cost of Revenue | 12.24M -- | 7.08M -- | 15.51M +26.68% | 8.43M +19.04% | 26.17M +68.73% | 22.30M +164.48% | 45.77M +74.91% | 23.47M +5.26% | 31.88M -30.35% | 31.88M -- |
Cost of Goods and Services | -- -- | -- -- | 15.51M -- | -- -- | 26.17M +68.73% | 22.30M -- | 45.77M +74.91% | 23.47M +5.26% | 31.88M -30.35% | 31.88M -- |
Gross Profit | 605.58K -- | 317.75K -- | 648.72K +7.12% | 730.23K +129.81% | 2.06M +217.87% | 1.20M +64.52% | 2.75M +33.38% | 480.39K -60.01% | 927.75K -66.27% | 927.75K -- |
Operating Expenses | 275.02K -- | 198.46K -- | 379.95K +38.15% | 237.44K +19.64% | 866.25K +127.99% | 383.02K +61.31% | 1.03M +19.26% | 607.74K +58.67% | 2.93M +183.38% | 2.93M -- |
Selling, General and Administrative Expenses | 212.38K -- | 146.13K -- | 277.43K +30.63% | 213.60K +46.17% | 808.09K +191.28% | 352.17K +64.88% | 953.14K +17.95% | 540.19K +53.39% | 2.85M +198.81% | 2.85M -- |
Selling and Marketing Expenses | -- -- | -- -- | 37.49K -- | -- -- | 32.13K -14.28% | 20.56K -- | 41.61K +29.50% | 30.27K +47.21% | 50.18K +20.58% | 50.18K -- |
General and Administrative Expenses | -- -- | -- -- | 239.94K -- | -- -- | 775.96K +223.40% | 331.61K -- | 911.53K +17.47% | 509.92K +53.77% | 2.80M +206.95% | 2.80M -- |
Research and Development Expenses | 62.65K -- | 52.33K -- | 102.52K +63.66% | 23.84K -54.44% | 58.16K -43.27% | 30.84K +29.36% | 79.98K +37.52% | 67.56K +119.04% | 79.54K -0.55% | 79.54K -- |
Operating Income | 330.55K -- | 119.29K -- | 268.77K -18.69% | 492.79K +313.10% | 1.20M +344.92% | 818.37K +66.07% | 1.72M +43.61% | -127.35K -115.56% | -2.00M -216.46% | -2.00M -- |
Non-Operating Income (Loss) | -5.27K -- | -4.49K -- | -9.17K -74.06% | -6.74K -50.33% | -5.41K +41.07% | -18.14K -169.04% | 18.00K +432.98% | 129.43K +813.34% | 6.15M +34049.92% | 6.15M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 6.76M -- | 6.76M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | 788 -- | -- -- | 15.50K +1866.50% | -1.35K -- | -16.91K -209.12% | -4.22K -211.73% | -931.49K -5408.85% | -931.49K -- |
Net Interest Expense | 5.27K -- | 4.49K -- | 9.96K +89.01% | 6.74K +50.33% | 20.90K +109.84% | 16.79K +148.95% | -34.91K -267.02% | -133.65K -896.07% | -317.36K -809.07% | -317.36K -- |
Interest Expense | 5.27K -- | 4.49K -- | 9.96K +89.01% | 6.74K +50.33% | 20.90K +109.84% | 16.79K +148.95% | 41.19K +97.04% | 0 -100.00% | 45.96K +11.58% | 45.96K -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 76.10K -- | 133.65K -- | 363.31K +377.44% | 363.31K -- |
Pretax Income From Continuing Operations | 325.28K -- | 114.81K -- | 259.60K -20.19% | 486.05K +323.37% | 1.19M +358.56% | 800.23K +64.64% | 1.74M +45.77% | 2.08K -99.74% | 4.15M +139.01% | 4.15M -- |
Income Tax Expense | 21.22K -- | 3.89K -- | 15.01K -29.27% | 39.00K +903.37% | 220.65K +1370.24% | 40.03K +2.64% | 443.58K +101.03% | 234.61K +486.09% | 270.74K -38.96% | 270.74K -- |
Current Income Tax | -- -- | -- -- | 15.01K -- | -- -- | 220.65K +1370.24% | 40.03K -- | 443.58K +101.03% | 234.61K +486.09% | 270.74K -38.96% | 270.74K -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- |
Net Income | 304.06K -- | 110.92K -- | 244.59K -19.56% | 447.05K +303.04% | 969.75K +296.49% | 760.20K +70.05% | 1.29M +33.20% | -232.53K -130.59% | 3.88M +200.13% | 3.88M -- |
Net Income Attributable to Owners of the Company | 304.06K -- | 110.92K -- | 244.59K -19.56% | 447.05K +303.04% | 969.75K +296.49% | 760.20K +70.05% | 1.29M +33.20% | -232.53K -130.59% | 3.88M +200.13% | 3.88M -- |
Net Income Attributable to Common Stockholders | 304.06K -- | 110.92K -- | 244.59K -19.56% | 447.05K +303.04% | 969.75K +296.49% | 760.20K +70.05% | 1.29M +33.20% | -232.53K -130.59% | 3.88M +200.13% | 3.88M -- |
Other Comprehensive Income | -172.48K -- | -24.03K -- | 63.04K +136.55% | 65.53K +372.74% | 68.18K +8.16% | -604.93K -1023.15% | 387 -99.43% | -46.62K +92.29% | -1.13K -393.02% | -1.13K -- |
Total Comprehensive Income | 131.59K -- | 86.89K -- | 307.62K +133.78% | 512.58K +489.90% | 1.04M +237.40% | 155.26K -69.71% | 1.29M +24.48% | -279.15K -279.79% | 3.88M +199.95% | 3.88M -- |
Total Comprehensive Income Attributable to Owners of the Company | 131.59K -- | 86.89K -- | 307.62K +133.78% | 512.58K +489.90% | 1.04M +237.40% | 155.26K -69.71% | 1.29M +24.48% | -279.15K -279.79% | 3.88M +199.95% | 3.88M -- |
Basic EPS | 0.01 -- | 0 -- | 0.01 -- | 0.02 -- | 0.87 +8600.00% | 0.64 +3100.00% | 1.06 +21.84% | -0.13 -120.31% | 1.66 +56.60% | 1.66 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | 0.01 -- | -- -- | 0.87 +8600.00% | 0.64 -- | 1.06 +21.84% | -0.13 -120.31% | 1.66 +56.60% | 1.66 -- |
Diluted EPS | 0.01 -- | 0 -- | 0.01 -- | 0.02 -- | 0.87 +8600.00% | 0.64 +3100.00% | 1.06 +21.84% | -0.13 -120.31% | 1.32 +24.53% | 1.32 -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | 0.01 -- | -- -- | 0.87 +8600.00% | 0.64 -- | 1.06 +21.84% | -0.13 -120.31% | 1.32 +24.53% | 1.32 -- |
You can ask Aime
What is the revenue and EPS growth rate for Haoxi Health year over year?What were the key takeaways from Haoxi Health’s earnings call?What were the key takeaways from Haoxi Health's earnings call?What factors drove the changes in Haoxi Health's revenue and profit?What is Haoxi Health's latest dividend and current dividend yield?What is the market's earnings forecast for Haoxi Health next quarter?Did Haoxi Health beat or miss consensus estimates last quarter?What is Haoxi Health's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
